Skip to content
MedCompare

Cyclophosphamide

Cancer & Oncology
Save $2,219/mo
203× cheaper

Cyclophosphamide for injection is an alkylating drug indicated for treatment of adults and pediatric patients with: Malignant Diseases: malignant lymphomas: Hodgkin’s disease, lymphocytic lymphoma, mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma; multiple myeloma, leukemias, mycos…

United States
$2,230
per month
India
$11
per month
You save
$2,219
99.51% cheaper in India
5.9K US scripts/yr$13.2M potential annual savings$13.3M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC7H15Cl2N2O2P

SMILES: C1CNP(=O)(OC1)N(CCCl)CCCl

Compare the price
US price$2,230per month
India price$11per month
You save$2,21999.51% less

Based on 30 units per month. US $74.34 vs India $0.37 per unit.

Total over 1 periodSave $2,219$2,230 → $11
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$13,315
Estimated travel cost
− $2,300
Net savings after travel
$11,015

Even after travel, you could come out ahead by about $11,015.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Cyclophosphamide is filled about 5.9K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$13.3M
If sourced from India
$65.3K
Potential annual savings
$13.2M
−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.